RELEReleases

Lovense Challenges the Persistent Orgasm Gap in Heterosexual Couples

While 95% of heterosexual men consistently reach orgasm during sex, only 65% of women report the same frequency. Lovense is now launching a campaign to address this long-standing disparity, arguing that the persistent gap is not merely a biological inevitability but a failure of shared intimacy and communication.

Bio & NewsJune 22, 2026358 reads0

The initiative, titled "Closing the Orgasm Gap Takes Two," seeks to shift the responsibility of sexual satisfaction from the individual to the partnership. Academic research supports the necessity of this shift; a 2026 Rutgers University study highlighted the psychological "devaluation" women experience when their pleasure is consistently ignored. Data from the Archives of Sexual Behavior underscores this, showing that 86% of lesbian women achieve orgasm regularly, suggesting that the discrepancy in heterosexual encounters is rooted in the standard "script" of penetration-focused sex rather than anatomy.

To bridge this divide, Lovense is promoting a two-pronged approach focusing on physical stimulation and emotional investment. The company argues that most heterosexual encounters overlook the combination of internal and external stimulation required by the majority of women. Products like the Osci 3 are designed to engage both the G-spot and clitoris simultaneously. Beyond hardware, the company emphasizes the role of the Lovense Remote App, which allows partners to synchronize their experiences, turning solitary stimulation into a collaborative act of feedback and attention.

CEO Dan Liu noted that technology serves only as a tool for a deeper issue. According to an internal company survey, 72% of female users purchased their first device after struggling for years with inconsistent satisfaction in partnered settings. By framing the orgasm gap as a shared responsibility rather than a private struggle, Lovense aims to force a conversation about the necessity of mutual investment in sexual health.

Comments (0)

Leave a comment

No comments yet. Be the first!